as attached

Date: 06th August 2026 To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Bandra Kurla Complex Mumbai- 400001 Bandra (E) Mumbai-400051 Security Code: 540596 Symbol: ERIS SUBJECT: INTIMATION UNDER REGULATION 30 AND OTHER APPLICABLE REGULATIONS OF SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 (SEBI LODR, 2015) Dear Sir/Madam, We would like to inform that the Company has drawn down a working capital term loan amounting to ₹64,40,00,000/- (Rupees Sixty Four Crores Forty Lakhs Only) from Axis Bank Limited to meet other short-term liabilities. The aggregate debt level of the company would, therefore, remain unchanged. In accordance with requirement of regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Para B of Part A of Schedule III and SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, details attached herein shall be taken on record. Thanking You, For Eris Lifesciences Limited Milind Talegaonkar Company Secretary & Compliance Officer Membership No: A26493 Encl: As above Agreements (viz. loan agreement(s) or any other agreement(s) which are binding and not in normal course of business, revision(s) or amendment(s) and termination(s) thereof: Sr. No. Particulars Details 1. name(s) of parties with whom the agreement is Axis Bank Limited (“Bank/Axis”) and Eris entered Lifesciences Limited (“Company”) 2. purpose of entering into the agreement The Company has today drawn down a working capital loan amounting to ₹64,40,00,000/- (Rupees Sixty Four Crores Forty Lakhs Only) from Axis Bank Limited to meet other short-term liabilities. The aggregate debt level of the company would, therefore, remain unchanged. 3. Size of agreement ₹ 64,40,00,000/- (Rupees Sixty Four Crores Forty Lakhs Only) 4. shareholding, if any, in the entity with whom the NIL agreement is executed 5. significant terms of the agreement (in brief) special NA rights like right to appoint directors, first right to share subscription in case of issuance of shares, right to restrict any change in capital structure etc. 6. whether, the said parties are related to NA promoter/promoter group/ group companies in any manner. If yes, nature of relationship 7. whether the transaction would fall within related NA party transactions? If yes, whether the same is done at “arm’s length” 8. in case of issuance of shares to the parties, details NA of issue price, class of shares issued 9. in case of loan agreements: ➢ details of lender/borrower, Axis Bank Limited ➢ nature of the loan, Working Capital Term Loan ➢ total amount of loan granted/taken, ₹ 64,40,00,000/- (Rupees Sixty Four Crores forty Lakhs Only) ➢ total amount outstanding, Term Loan: 91.37 Crores Working Capital Loan: 55 Crores ➢ date of execution of the loan The Sanction letter is executed on 05th August agreement/sanction letter 2026. ➢ details of the security provided to the lenders / The Bank willl have a second charge on assets by the borrowers for such loan or in case (both primary and collateral) already created for outstanding loans lent to a party or borrowed its existing working capital credit facilities. from a party become material on a cumulative basis; 10. any other disclosures related to such agreements, NA viz., details of nominee on the board of directors of the listed entity, potential conflict of interest arising out of such agreements, etc. 11. in case of termination or amendment of NA agreement, listed entity shall disclose additional details to the stock exchange(s): i. name of parties to the agreement; ii. nature of the agreement; iii. date of execution of the agreement; iv. details of amendment and impact thereof or reasons of termination and impact thereof.